Select Page

LIFE

SCIENCE

BUSINESS

Drug Delivery Technology

 

Cell Therapy Production/

Biopharmaceutical Production

Immunology/Microbiology

 

business

Business
Development

products

Product
Launch

technology

Technology
Assessment

Randy-Engler

Randall Engler

CEO, Sea.Bio

Randy focuses the efforts of Sea.Bio on global business development of B2B technologies in therapeutic, diagnostic and device markets.  With a significant technical background and years of business development, sales and marketing experience, Randy can help you make better decisions by defining, targeting and implementing your business plans for successful commercialization of your technology.